INVERSAGO-PHARMA
24.1.2023 13:01:37 CET | Business Wire | Press release
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced that François Ravenelle, Ph.D., Chief Executive Officer, and Glenn Vraniak, MBA, Chief Financial Officer, will host investor meetings during the Private Company Exhibition at the 2023 SVB Securities Global Biopharma Conference being held January 31 through February 2, 2023.
For additional information or to request a meeting with management, please contact conference representatives.
About Inversago Pharma
Inversago Pharma is a privately owned, clinical stage, Canadian biotech company, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting CB1 inverse agonists. Inversago aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic kidney disease (DKD), including diabetic nephropathy (DN), type 1 and type 2 diabetes (T1D / T2D), non-alcoholic steatohepatitis (NASH), complications of obesity and hypertriglyceridemia (HTG), as well as fibrotic indications like progressive fibrosis-interstitial lung disease (PF-ILD), including idiopathic pulmonary fibrosis (IPF) and other conditions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005328/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Canoga Perkins and Druid Deliver FRER-Enabled Resilience for Mission-Critical Private 5G Networks24.2.2026 13:00:00 CET | Press release
Canoga Perkins and Druid Software showcased their partnership with Canoga Perkins demonstrating Frame Replication and Elimination for Reliability (FRER) at the Winter 2025 Druid Demo Days. This marks a new era of networking for mission critical applications across industries such as mining, industrial automation, and smart manufacturing. FRER is the foremost data protection mechanism delivering unmatched, lossless delivery of mission critical data. Canoga Perkins and Druid created a Private 5G network where SyncMetra protected traffic between the Druid’s Raemis core and the Radio Area Network delivering hitless failover and continuous video traffic. Canoga Perkins is pleased to announce their return to MWC Barcelona in 2026, where they will once again showcase their advanced technical demonstration highlighting FRER and cutting‑edge 5G TSN solutions. The Canoga Perkins team will be on-site to discuss the latest advancements in deterministic networking, including Frame Replication and E
Quantum XChange Advances EUCC Milestone and Enterprise Scalability with Latest Release of Phio TX24.2.2026 13:00:00 CET | Press release
New EUCC Compliance Mode and Enhanced Hive Architecture Strengthen Security for Regulated European and Global Networks Quantum XChange today announced the latest release of its cryptographic management platform Phio TX® which introduces a new European Union Cybersecurity Certification (EUCC) compliance mode and significant enhancements to its Hive architecture to support massive-scale, distributed deployments. The release marks a critical milestone toward full EUCC validation for Phio TX and reinforces the company’s commitment to meeting rigorous international security standards for customers operating in regulated European markets. EUCC is a European Union–wide certification framework based on Common Criteria (ISO/IEC 15408), providing independent evaluation of Information and Communications Technology (ICT) products against high EU cybersecurity standards. Similar in importance to FIPS validation in the United States, EUCC validation is increasingly critical for organizations handlin
Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 202624.2.2026 12:39:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the TD Cowen 46th Annual Healthcare Conference in Boston, MA, from March 2-4, 2026 and will participate in a fireside chat on March 3, 2026 at 10:30am ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through
Simon-Kucher Selects Navan to Modernize Global Travel Program24.2.2026 11:00:00 CET | Press release
Global consultancy to consolidate travel operations with Navan across more than a dozen markets Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Simon-Kucher, the world’s leading commercial growth and pricing consultancy, as its global travel partner. Simon-Kucher teams will now have access to Navan’s AI-powered travel management platform across more than a dozen markets, including in the North American, European, and APAC regions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224745907/en/ Simon-Kucher Selects Navan to Modernize Global Travel Program “Our work is increasingly global, and travel remains essential to how we collaborate with clients and with one another,” said Thomas Wohlan, Director of Travel Management at Simon-Kucher. “To support that at scale, we needed a modern travel platform that brings consistency across countries and simplifi
Khazna Awarded Uptime Tier III Certification of Design Documents for Ajman, UAE Facility, Largest in Company’s Portfolio24.2.2026 10:00:00 CET | Press release
Set to Achieve 1st Certified AI Data Center with Liquid Cooling in Middle East Uptime Institute, the Global Digital Infrastructure Authority, today announced that Khazna Data Centers, a global leader in hyperscale digital infrastructure, has achieved the Uptime Institute Tier III Certification of Design Documents (TCDD) award for its newest 100 MW AI-optimized data center, QAJ01 —set to be the first certified AI data center with liquid cooling in the Middle East and North Africa region. Representing the largest facility in Khazna’s portfolio, this state-of-the-art development features 20 data halls, each delivering 5 MW of IT capacity, purpose-built to meet the demands of next-generation artificial intelligence (AI) workloads. The certification underscores Khazna’s commitment to designing world-class, resilient, and efficient data center infrastructure in alignment with the industry’s most rigorous global standards. Located in Ajman, United Arab Emirates, the new facility has been desi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom